Dachshund Alliance of Southern Ontario

Mucopolysaccharidosis Type 111A (MPS 111A) In Standard Dachshunds

Mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A, is a genetic lysosomal storage disorder that affects the breakdown of glycosaminoglycans (GAGs) in the body. In Dachshunds, this condition is specifically referred to as the "Dachshund type" due to its occurrence in the breed.

Key Points about MPS IIIA in Dachshunds:

  1. Genetic Cause:
  • MPS IIIA is caused by a deficiency of the enzyme heparan N-sulfatase (SGSH), which is necessary for the degradation of heparan sulfate, a type of GAG.
  • The condition is inherited in an autosomal recessive manner, meaning that a dog must inherit two copies of the mutated gene (one from each parent) to develop the disease.
  1. Symptoms:
  • Affected Dachshunds may show symptoms related to neurological deterioration, as the accumulation of GAGs primarily affects the central nervous system.
  • Common symptoms include behavioral changes, progressive loss of motor skills, ataxia (loss of coordination), seizures, and eventual cognitive decline.
  • The onset of symptoms typically occurs in young dogs, and the progression of the disease can be rapid.
  1. Diagnosis:
  • Diagnosis is usually made through a combination of clinical signs, genetic testing, and enzyme assays to confirm the deficiency of the SGSH enzyme.
  • Genetic testing can identify carriers of the mutated gene, which is essential for breeding decisions to avoid producing affected puppies.
  1. Treatment:
  • Currently, there is no cure for MPS IIIA in Dachshunds. Treatment is primarily supportive, focusing on managing symptoms and maintaining the dog’s quality of life.
  • Research is ongoing into potential therapies, including enzyme replacement therapy and gene therapy, but these are not yet widely available.
  1. Prognosis:
  • The prognosis for dogs with MPS IIIA is generally poor, with most affected dogs experiencing significant neurological decline and a shortened lifespan.
  • Early detection through genetic testing is crucial for managing the disease and making informed breeding decisions. If you suspect a Dachshund may have MPS IIIA or are concerned about the genetic risk, it's important to consult with a veterinarian or a veterinary geneticist for testing and advice.